Phenominer Database Results (5 results)

 

Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Clinical Measurement Notes Record ID Study ID
ACI/SegHsd percentage of study population developing mammary tumors during a period of time bilateral ovariectomy then 17 beta-estradiol (27.5 mg) (for 140 days) Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601 mammary gland integrity trait female 201 days-203 days 11 0.0 % manual palpation method mammary gland 0 0 11379 76
ACI/SegHsd percentage of study population developing mammary tumors during a period of time 17 beta-estradiol (27.5 mg) (between 193 and 199 days) Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800 mammary gland integrity trait female 143 days-259 days 22 94.0 % manual palpation method 0 crystalline implant 0 65764 81
ACI/SegHsd percentage of study population developing mammary tumors during a period of time 17 beta-estradiol (27.5 mg) (for 197 days) Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601 mammary gland integrity trait female 160 days-260 days 21 100.0 % manual palpation method mammary gland 0 0 65549 76
ACI/SegHsd percentage of study population developing mammary tumors during a period of time 17 beta-estradiol (27.5 mg) (between 147 and 195 days) Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30 mammary gland integrity trait female 206 days-264 days 31 100.0 % manual palpation method 0 0 mean 66112 144
ACI/SegHsd percentage of study population developing mammary tumors during a period of time control condition Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601 mammary gland integrity trait female 201 days-518 days 3 0.0 % manual palpation method mammary gland 0 0 11378 76